MedPath

Inreda Diabetic B.V.

πŸ‡³πŸ‡±Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Portable Artificial Pancreas Applied for Youth and Adolescents

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Device: Open-loop control
Device: Bi-hormonal closed-loop control
First Posted Date
2022-09-16
Last Posted Date
2023-08-14
Lead Sponsor
Inreda Diabetic B.V.
Target Recruit Count
20
Registration Number
NCT05543850
Locations
πŸ‡³πŸ‡±

Rijnstate Ziekenhuis, Arnhem, Gelderland, Netherlands

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Insulin Lispro Cartridge [Lyumjev]
Drug: Insulin Lispro Cartridge
First Posted Date
2022-08-19
Last Posted Date
2023-04-18
Lead Sponsor
Inreda Diabetic B.V.
Target Recruit Count
12
Registration Number
NCT05508061
Locations
πŸ‡³πŸ‡±

Slingeland Hospital, Doetinchem, Gelderland, Netherlands

πŸ‡³πŸ‡±

Hospital Gelderse Vallei, Ede, Gelderland, Netherlands

πŸ‡³πŸ‡±

Rijnstate Hospital, Arnhem, Gelderland, Netherlands

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

Phase 2
Withdrawn
Conditions
Diabetes Mellitus, Type 1
Interventions
First Posted Date
2022-07-12
Last Posted Date
2024-01-03
Lead Sponsor
Inreda Diabetic B.V.
Registration Number
NCT05454709
Locations
πŸ‡³πŸ‡±

ZGT hospital, Almelo, Overijssel, Netherlands

Β© Copyright 2025. All Rights Reserved by MedPath